Dataset Information


Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10.

ABSTRACT: Searching for new strategies for effective elimination of human prostate cancer cells, we investigated the cooperative cytotoxic action of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and two platinum-based complexes, cisplatin or LA-12, and related molecular mechanisms. We demonstrated a notable ability of cisplatin or LA-12 to enhance the sensitivity of several human prostate cancer cell lines to TRAIL-induced cell death via an engagement of mitochondrial apoptotic pathway. This was accompanied by augmented Bid cleavage, Bak activation, loss of mitochondrial membrane potential, activation of caspase-8, -10, -9, and -3, and XIAP cleavage. RNAi-mediated silencing of Bid or Bak in Bax-deficient DU 145 cells suppressed the drug combination-induced cytotoxicity, further underscoring the involvement of mitochondrial signaling. The caspase-10 was dispensable for enhancement of cisplatin/LA-12 and TRAIL combination-induced cell death and stimulation of Bid cleavage. Importantly, we newly demonstrated LA-12-mediated enhancement of TRAIL-induced cell death in cancer cells derived from human patient prostate tumor specimens. Our results provide convincing evidence that employing TRAIL combined with cisplatin/LA-12 could contribute to more effective killing of prostate cancer cells compared to the individual action of the drugs, and offer new mechanistic insights into their cooperative anticancer action.

SUBMITTER: Vondalova Blanarova O 

PROVIDER: S-EPMC5705153 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3132005 | BioStudies
2012-01-01 | S-EPMC3389262 | BioStudies
2008-01-01 | S-EPMC2948486 | BioStudies
2013-01-01 | S-EPMC4164233 | BioStudies
1000-01-01 | S-EPMC3542599 | BioStudies
2010-01-01 | S-EPMC3638721 | BioStudies
2009-01-01 | S-EPMC2822702 | BioStudies
1000-01-01 | S-EPMC1852827 | BioStudies
1000-01-01 | S-EPMC5931984 | BioStudies
1000-01-01 | S-EPMC3158540 | BioStudies